BridgeBio Pharma (BBIO) Other Gross PP&E Adjustments (2018 - 2026)
BridgeBio Pharma recorded quarterly Other Gross PP&E Adjustments of -$19.4 million in Q1 2026, up 32.48% quarter-over-quarter from -$28.8 million in Q4 2025, and down 111.94% year-over-year from $162.8 million in Q1 2025.
BridgeBio Pharma's Other Gross PP&E Adjustments history runs 9 years deep, the most recent figure standing at -$19.4 million for Q1 2026.
- In Q1 2026, Other Gross PP&E Adjustments fell 111.94% year-over-year to -$19.4 million; the TTM figure through Mar 2026 stood at -$19.4 million (down 111.94% YoY), while the FY2025 annual figure was -$28.8 million, down 7.05% from the prior year.
- Other Gross PP&E Adjustments came in at -$19.4 million for Q1 2026 at BridgeBio Pharma, up from -$28.8 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$7.3 million in Q3 2025 to a low of -$29.4 million in Q4 2023.
- A 5-year average of -$15.8 million and a median of -$14.5 million in 2023 frame the typical range for Other Gross PP&E Adjustments.
- Across the five-year window, Other Gross PP&E Adjustments surged 42.38% in 2024 and slumped 111.94% in 2026, its largest moves.
- BridgeBio Pharma's Other Gross PP&E Adjustments stood at -$26.8 million in 2022, then slipped by 9.53% to -$29.4 million in 2023, then gained by 8.48% to -$26.9 million in 2024, then declined by 7.05% to -$28.8 million in 2025, then soared by 32.48% to -$19.4 million in 2026.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered -$19.4 million, -$28.8 million, and -$7.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | -19.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.43 Mn |
| Mar 31, 2026 | -19.43 Mn |
| Dec 31, 2025 | -28.77 Mn |
| Dec 31, 2025 | -28.77 Mn |
| Sep 30, 2025 | -7.25 Mn |
| Sep 30, 2025 | -7.25 Mn |
| Jun 30, 2025 | -7.59 Mn |
| Jun 30, 2025 | -7.59 Mn |
| Mar 31, 2025 | -9.17 Mn |
| Mar 31, 2025 | -9.17 Mn |
| Dec 31, 2024 | -26.88 Mn |
| Dec 31, 2024 | -26.88 Mn |
| Sep 30, 2024 | -10.23 Mn |
| Sep 30, 2024 | -10.23 Mn |
| Jun 30, 2024 | -8.47 Mn |
| Jun 30, 2024 | -8.47 Mn |
| Mar 31, 2024 | -9.85 Mn |
| Mar 31, 2024 | -9.85 Mn |
| Dec 31, 2023 | -29.37 Mn |
| Dec 31, 2023 | -29.37 Mn |
| Sep 30, 2023 | -9.93 Mn |
| Sep 30, 2023 | -9.93 Mn |
| Jun 30, 2023 | -14.70 Mn |
| Jun 30, 2023 | -14.70 Mn |
| Mar 31, 2023 | -14.55 Mn |
| Mar 31, 2023 | -14.55 Mn |
| Dec 31, 2022 | -26.81 Mn |
| Dec 31, 2022 | -26.81 Mn |
| Sep 30, 2022 | -15.97 Mn |
| Sep 30, 2022 | -15.97 Mn |
| Jun 30, 2022 | -14.05 Mn |
| Jun 30, 2022 | -14.05 Mn |
| Mar 31, 2022 | -15.74 Mn |
| Mar 31, 2022 | -15.74 Mn |
| Dec 31, 2021 | -26.14 Mn |
| Dec 31, 2021 | -26.14 Mn |
| Sep 30, 2021 | -22.08 Mn |
| Sep 30, 2021 | -22.08 Mn |
| Jun 30, 2021 | -22.34 Mn |
| Jun 30, 2021 | -22.34 Mn |
| Mar 31, 2021 | -17.52 Mn |
| Mar 31, 2021 | -17.52 Mn |
| Dec 31, 2020 | -22.09 Mn |
| Dec 31, 2020 | -22.09 Mn |
| Sep 30, 2020 | -14.35 Mn |
| Sep 30, 2020 | -14.35 Mn |
| Jun 30, 2020 | -19.07 Mn |
| Jun 30, 2020 | -19.07 Mn |
| Mar 31, 2020 | -12.00 Mn |
| Mar 31, 2020 | -12.00 Mn |
| Dec 31, 2019 | -2.22 Mn |
| Dec 31, 2019 | -2.22 Mn |
| Sep 30, 2019 | -1.57 Mn |
| Sep 30, 2019 | -1.57 Mn |
| Jun 30, 2019 | -3.32 Mn |
| Jun 30, 2019 | -3.32 Mn |
| Dec 31, 2018 | -772,000.00 |
| Dec 31, 2018 | -772,000.00 |